Date published: 2025-11-27

1-800-457-3801

SCBT Portrait Logo
Seach Input

FNDC1 Inhibitors

FNDC1 inhibitors represent a class of chemical compounds that specifically target the protein FNDC1 (Fibronectin Type III Domain Containing 1). FNDC1 is a member of the fibronectin type III domain family, which is characterized by the presence of fibronectin-like repeats. These repeats are involved in various protein-protein interactions that play a role in cellular processes such as signal transduction, structural organization, and cell adhesion. The inhibitors in this class are designed to modulate or suppress the activity of FNDC1, often by binding to its active sites or interfering with its ability to interact with other cellular proteins. By inhibiting FNDC1, these compounds can affect pathways or biological mechanisms in which this protein is a key mediator, potentially leading to alterations in processes such as cellular communication or the maintenance of cellular architecture.

Chemically, FNDC1 inhibitors can belong to various classes of molecules, including small organic compounds, peptides, or synthetic analogs designed to mimic specific binding patterns or motifs. The design of these inhibitors often involves detailed structural analyses of FNDC1 to identify active binding domains that are critical for its function. Once these domains are identified, inhibitors are synthesized to either compete for the same binding partners or disrupt the structural integrity of the protein. This inhibition can lead to downstream effects on signaling cascades or protein assemblies that FNDC1 is involved in. In some cases, these compounds are fine-tuned to achieve selective inhibition of FNDC1 over other related proteins, ensuring that off-target effects are minimized.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

ML-7 hydrochloride

110448-33-4sc-200557
sc-200557A
10 mg
50 mg
$89.00
$262.00
13
(1)

Inhibits myosin light chain kinase. If FNDC1 interacts with actin-cytoskeleton dynamics, ML7 can be of relevance.

Calpeptin

117591-20-5sc-202516
sc-202516A
10 mg
50 mg
$119.00
$447.00
28
(1)

Calpain inhibitor. If FNDC1 undergoes calpain-mediated proteolysis, this inhibitor can affect its turnover.

KN-62

127191-97-3sc-3560
1 mg
$133.00
20
(2)

CaM kinase II inhibitor. Relevant if FNDC1 has functional intersections with Ca2+-mediated signaling.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$103.00
$293.00
$465.00
15
(1)

Protein kinase C inhibitor. Could impact FNDC1 if it's involved in pathways mediated by PKC.

Anacardic Acid

16611-84-0sc-202463
sc-202463A
5 mg
25 mg
$100.00
$200.00
13
(1)

Histone acetyltransferase inhibitor. If FNDC1's function is regulated by acetylation, this compound could influence its activity.

EX 527

49843-98-3sc-203044
5 mg
$85.00
32
(1)

Sirtuin-1 inhibitor. Relevant if FNDC1 undergoes deacetylation by SIRT1, impacting its function or stability.

A-443654

552325-16-3sc-507339
1 mg
$140.00
(0)

AKT inhibitor. If FNDC1 interacts or is involved in pathways mediated by AKT signaling, its activity might be influenced.

INK 128

1224844-38-5sc-364511
sc-364511A
5 mg
50 mg
$315.00
$1799.00
(1)

mTOR inhibitor. If FNDC1's function or expression is influenced by mTOR, this inhibitor can modulate its activity.

A-769662

844499-71-4sc-203790
sc-203790A
sc-203790B
sc-203790C
sc-203790D
10 mg
50 mg
100 mg
500 mg
1 g
$180.00
$726.00
$1055.00
$3350.00
$5200.00
23
(2)

AMPK activator. If FNDC1 operates within or parallel to the AMPK pathway, its activity might be influenced.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$134.00
$215.00
$440.00
$496.00
19
(2)

A potent, irreversible proteasome inhibitor. If FNDC1 is regulated by proteasomal degradation, this compound could stabilize it.